MEF2C as oncogene for early thymic progenitor acute lymphoblastic leukemia in children

Dr. Jules Meijerink Oncology & Hematology, Erasmus University, Rotterdam, The Netherlands im Ferdinand-Bergen-Auditorium des HPI